Privately Held Digital

Health Company

This is a privately held digital health company. The Company’s technology and services measure and analyze typing cadence (TC), for early detection and continuous monitoring of Central Nervous System (CNS) diseases and injuries. This company is the first provider of quantitative, sub-clinical measures of neurocognitive function with extreme granularity and stunning statistical power. 

Regenerative Bone

Medicine Company

This company was launched to develop and commercialize a class of drugs based on targeting mesenchymal stem cells (MSCs) to various sites of clinical relevance. The company's new findings have currently been demonstrated in a number of animal models for osteonecrosis, fracture healing, osteoporosis, and inflammatory arthritis. The potential opportunity for this company is to develop these drugs addressing a need for effective stem cell treatments in osteonecrosis, fracture healing, osteoporosis, and inflammatory arthritis.

Virtual Reality Company

Status: Pre-A Series

This company develops a line of patent pending award winning solutions for a full-on immersive virtual reality experience. These solutions include input and feedback hardware and software components to interact with virtual environments and address the issue of simulator sickness in first person applications.